Seismic Therapeutic Highlights Preclinical Data of S-1117 for the Treatment of Autoimmune Disorders at AAN 2024
Shots: Seismic presented the preclinical data of S-1117, Fc-fused pan-IgG protease...
Shots: Seismic presented the preclinical data of S-1117, Fc-fused pan-IgG protease...
Shots: Merus highlighted preclinical results of zenocutuzumab, HER2 × HER3 b...
Shots: Coherus’ presentation was titled as,
Shots: Microbot Medical concludes its pivotal GLP pre-clinical study in porcine mo...
Shots: Daiichi Sankyo will receive $4B up front ($1.5B for ifinatamab deruxtecan d...
Shots: Monte Rosa Therapeutics will receive $50M up front and is eligible to recei...
Incisive News in 3 Shots.